glp-1 medications and alcohol A new clinical trial supported by the National Institutes of Health (NIH) found that a medication commonly used for weight loss, such as semaglutide, may also help reduce heavy drinking in individuals GLP-1 Agonist Addiction Treatment |

Amgen updated data from its Phase I study of the weight loss drug AMG133 at the 2022 American Heart Association Annual Scientific Sessions (AHA)

Once a niche topic in endocrinology, this naturally occurring gut hormone has been thrust into the global spotlight, heralded as a revolutionary tool in the management of type 2 diabetes and, most notably, weight loss

Medical Management Membership: $99/mo Perfect if you're purely focused on health

It combines fiber principles with appetite-regulating botanicals and nutrients, addressing both gut and metabolic pathways simultaneously

Gonzalez-Rellan MJ et al

49,50 In this trial exenatide was safe and well-tolerated, with no withdrawals due to drug adverse effects